Isoprenoid Alcohols Restore Protein Isoprenylation in a Time-Dependent Manner Independent of Protein Synthesis

Lipids

Volumn 38, Issue 7, 2003, Pages 751-759

  Ownby, Susan E ^a   Hohl, Raymond J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLS; CELLS; DEHYDROGENATION; ENZYME INHIBITION; LIPIDS;

METABOLIC PATHWAYS;

PROTEINS;

ALCOHOL DERIVATIVE; ISOPRENOID; MEVALONIC ACID; MEVINOLIN; RAP PROTEIN; RAS PROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; ISOPRENYLATION; LIPID METABOLISM; METABOLIC REGULATION; MOUSE; NONHUMAN; PROTEIN MODIFICATION; PROTEIN SYNTHESIS INHIBITION; TRANSLATION REGULATION;

ALCOHOLS; ANIMALS; CYCLOHEXIMIDE; DITERPENES; FARNESOL; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KINETICS; LOVASTATIN; MICE; MONOMERIC GTP-BINDING PROTEINS; NIH 3T3 CELLS; PROTEIN BIOSYNTHESIS; PROTEIN ISOPRENYLATION; PROTEIN SYNTHESIS INHIBITORS; RAS PROTEINS; TERPENES;

ANIMALIA;

EID: 0242331163     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-003-1123-8     Document Type: Article

References (37)

1. Rowinsky, E.K., Windle, J.J., and Von Hoff, D.D. (1999) RAS Protein Farnesyltransferase: A Strategic Target for Anticancer Treatment, J. Clin. Oncol. 17, 3631-3652.
2. Fliesler, S.J., and Keller, R.K. (1995) Metabolism of [3H]Farnesol to Cholesterol and Cholesterogenic Intermediates in the Living Rat Eye, Biochem. Biophys. Res. Commun. 21, 695-702.
3. Crick, D.C., Andres, D.A., and Waechter, C.J. (1995) Farnesol Is Utilized for Protein Isoprenylation and the Biosynthesis of Cholesterol in Mammalian Cells, Biochem. Biophys. Res. Commun. 211, 590-599.
4. McGuire, T.F., Qian, Y., Vogt, A., Hamilton, A.D., and Sebti, S.M. (1996) Platelet Derived Growth Factor Receptor Tyrosine Kinase Phosphorylation Requires Protein Geranylgeranylation but Not Farnesylation, J. Biol. Chem. 271, 27402-27407.
5. Vogt, A., Qian, Y., McGuire, T.F., Hamilton, A.D., and Sebti, S.M. (1996) Protein Geranylgeranylation, Not Farnesylation, Is Required for the G1 to S Phase Transition in Mouse Fibroblasts, Oncogene 13, 1991-1999.
6. Ownby, S.E., and Hohl, R.J. (2002) Farnesol and Geranylgeraniol: Prevention and Reversion of Lovastatin-Induced Effects in NIH3T3 Cells, Lipids 37, 185-192.
7. Li, X., Li, L., Tupper, J.C., Bannerman, D.D., Winn, R.K., Sebti, S.M., Hamilton, A.D., and Harlan, J.M. (2002) Inhibition of Protein Geranylgeranylation and RhoA/RhoA Kinase Pathway Induces Apoptosis in Human Endothelial Cells, J. Biol. Chem. 277, 15309-15316.
8. Crick, D.C., Andres, D.A., and Waechter, C.J. (1997) Geranylgeraniol Promotes Entry of UT-2 Cells into the Cell Cycle in the Absence of Mevalonate, Exp. Cell Res. 231, 302-307.
9. Crick, D.C., Andres, D.A., and Waechter, C.J. (1998) Geranylgeraniol Overcomes the Block of Cell Proliferation by Lovastatin in C6 Glioma Cells, J. Neurochem. 70, 2397-2405.
10. Crick, D.C., Waechter, C.J., and Andres, D.A. (1994) Utilization of Geranylgeraniol for Protein Isoprenylation in C6 Glial Cells, Biochem. Biophys. Res. Commun. 205, 955-961.
11. Bentinger, M., Grunler, J., Peterson, E., Swiezewska, E., and Dallner, G. (1998) Phosphorylation of Farnesol in Rat Liver Microsomes: Properties of Famesol Kinase and Farnesyl Phosphate Kinase, Arch. Biochem. Biophys. 353, 191-198.
12. Westfall, D., Aboushadi, N., Shackelford, J.E., and Krisans, S.K. (1997) Metabolism of Farnesol: Phosphorylation of Farnesol by Rat Liver Microsomes and Peroxisomal Fractions, Biochem. Biophys. Res. Commun. 230, 562-568.
13. Koch, G., Benz, C., Schmidt, G., Olenik, C., and Aktories, K. (1997) Role of Rho Protein in Lovastatin-Induced Breakdown of Actin Cytoskeleton, J. Pharmacol. Exp. Ther. 283, 901-909.
14. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951) Protein Measurement with the Folin Phenol Reagent, J. Biol. Chem. 193, 265-275.
15. Hohl, R.J., and Lewis, K. (1995) Differential Effects of Monoterpenes and Lovastatin on RAS Processing, J. Biol. Chem. 29, 17508-17512.
16. Connally, H.E., Hamar, D.W., and Thrall, M.A. (2000) Inhibition of Canine and Feline Alcohol Dehydrogenase Activity by Fomepizole, Am. J. Vet. Res. 61, 450-455.
17. Keung, W.M. (1991) Human Liver Alcohol Dehydrogenase Catalyzes the Oxidation of the Intermediary Alcohols of the Shunt Pathway of Mevalonate Metabolism, Biochem. Biophys. Res. Commun. 174, 701-707.
18. Bradfute, D.L., and Simoni, R.D. (1994) Non-sterol Compounds That Regulate Cholesterolgenesis, J. Biol. Chem. 269, 6645-6650.
19. Correll, C.C., Ng, L., and Edwards, P.A. (1994) Identification of Famesol as the Non-sterol Derivative of Mevalonic Acid Required for the Accelerated Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase, J. Biol. Chem. 269, 17390-17393.
20. Meigs, T.E., Roseman, D.S., and Simoni, R.D. (1996) Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Degradation by the Nonsterol Mevalonate Metabolite Farnesol in vivo, J. Biol. Chem. 271, 7916-7922.
21. Meigs, T.E., and Simoni, R.D. (1997) Farnesol as a Regulator of HMG-CoA Reductase Degradation: Characterization and Role of Farnesyl Pyrophosphatase, Arch. Biochem. Biophys. 345, 1-9.
22. Bringmann, A., Skatchkov, S.N., Faude, F., Enzmann, V., and Reichenbach, A. (2000) Farnesol Modulates Membrane Currents in Human Retinal Glial Cells, J. Neurosci. Res. 62, 396-402.
23. Beedle, A.M., and Zamponi, G.W. (2000) Block of Voltage-Dependent Calcium Channels by Aliphatic Monoamines, Biophys. J. 79, 260-270.
24. 2+ Channels in Vascular Smooth Muscle Cells, J. Biol. Chem. 272, 32240-32246.
25. Roullet, J.-B., Spaetgens, R.L., Burlingame, T., Feng, Z.-P., and Zamponi, G.W. (1999) Modulation of Neuronal Voltage-Gated Calcium Channels by Farnesol, J. Biol. Chem. 274, 25439-25446.
26. Hanley, K., Kömüves, L.G., Ng, D.C., Schoonjans, K., He, S.S., Lau, P., Bikel, D.D., Williams, M.L., Elias, P.M., Auwerx, J., et al. (2000) Famesol Stimulates Differentiation in Epidermal Keratinocytes via PPARα, J. Biol. Chem. 275, 11484-11491.
27. Forman, B.M., Goode, E., Chen, J., Oro, A.E., Bradley, D.J., Perlmann, T., Noonan, D.J., Burka, L.T., McMorris, T., Lamph, W.W., et al. (1995) Identification of a Nuclear Receptor That Is Activated by Farnesol Metabolites, Cell 81, 687-693.
28. Haug, J.S., Goldner, C.M., Yazlovitskaya, E.M., Voziyan, P.A., and Melnykovych, G. (1994) Directed Cell Killing (apoptosis) in Human Lymphoblastoid Cells Incubated in the Presence of Farnesol: Effect of Phosphatidylcholine, Biochim. Biophys. Acta 1223, 133-140.
29. Wright, M.M., Henneberry, A.L., Lagace, T.A., Ridgway, N.D., and McMaster, C.R. (2001) Uncoupling Farnesol-Induced Apoptosis from Its Inhibition of Phosphatidylcholine Synthesis, J. Biol. Chem. 276, 25254-25261.
30. Adany, I., Yazlovitskaya, E.M., Haug, J.S., Voziyan, P.A., and Melnykovych, G. (1994) Differences in Sensitivity to Farnesol Toxicity Between Neoplastically- and Non-neoplastically-Derived Cells in Culture, Cancer Lett. 79, 175-179.
31. Rioja, A., Pizzey, A.R., Marson, C.M., and Thomas, N.S.B. (2000) Preferential Induction of Apoptosis of Leukaemic Cells by Farnesol, FEBS Lett. 467, 291-295.
32. Ohizumi, H., Masuda, Y., Nakajo, S., Sakai, I., Ohsawa, S., and Nakaya, K. (1995) Geranylgeraniol Is a Potent Inducer of Apoptosis in Tumor Cells, J. Biochem. 117, 11-13.
33. Nakaya, M., Masuda, Y., Mihara, S., Aiuchi, T., Shibayama-Imazu, T., Nakajo, S., and Nakaya, K. (1999) Analysis of Caspases That Are Activated During Apoptosis in Leukemia U937 Cells in Response to Geranylgeraniol, Anticancer Res. 19, 5063-5068.
34. Masuda, Y., Nakaya, M., Aiuchi, T., Hashimoto, S., Nakajo, S., and Nakaya, K. (2000) The Mechanism of Geranylgeraniol-Induced Apoptosis Involves Activation, by a Caspase-3-like Protease, of a c-Jun N-Terminal Kinase Signaling Cascade and Differs from Mechanisms of Apoptosis Induced by Conventional Chemotherapeutic Drugs, Leuk. Res. 24, 937-950.
35. Forman, B.M., Ruan, B., Chen, J., Schroepfer, G.J., Jr., and Evans, R.M. (1997) The Orphan Nuclear Receptor LXRα Is Positively and Negatively Regulated by Distinct Products of Mevalonate Metabolism, Proc. Natl. Acad. Sci. USA 94, 10588-10593.
36. Lehmann, J.M., Kliewer, S.A., Moore, L.B., Su, J.-L., Sundseth, S.S., Winegar, D.A., Blanchard, D.E., Spencer, T.A., and Willson, T.M. (1997) Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway, J. Biol. Chem. 272, 3137-3140.
37. Holstein, S.A., Wohlford-Lenane, C.L., and Hohl, R.J. (2002) Consequences of Mevalonate Depletion: Differential Transcriptional, Translational, and Post-translational Up-regulation of Ras, Rapla, RhoA, and RhoB, J. Biol. Chem. 277, 10678-10682.